Showing 1 - 13 results of 13 for search 'Kristian Reich', query time: 0.08s Refine Results
  1. 1
    Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga Spirulina platensis in the Treatment of Children with Molluscum Contagiosum

    Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga Spirulina platensis in the Treatment of Children with Mo... by Karoline Jungclaus, Rosa Mascarenhas, Oscar Tellechea, Jeremias L. K. Reich, Kristian Reich

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic review

    Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic review by Alexander Nast, Corinna Dressler, Christopher Schuster, Daniel Saure, Matthias Augustin, Kristian Reich

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study

    Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study by Janine Topp, Matthias Augustin, Kathrin von Usslar, Ramona Gosau, Kristian Reich, Michael Reusch, Christine Blome

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Matching-adjusted indirect comparison (MAIC) results confirmed by head-to-head trials: a case study in psoriasis

    Matching-adjusted indirect comparison (MAIC) results confirmed by head-to-head trials: a case study in psoriasis by James Signorovitch, Joris Diels, Suzy Van Sanden, Agata Schubert, Fareen Hassan, Pushpike Thilakarathne, Bulent Ozturk, Norma Barthelmes, Kristian Reich

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials

    Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials by Kristian Reich, Diamant Thaçi, Georg Stingl, Jens Strodl Andersen, Line Conradsen Hiort, Michala Oron Lexner, David Winkler, Carle Paul

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)

    Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA) by Kristian Reich, Luca Bianchi, Abdallah Khemis, Julia-Tatjana Maul, Athanasios Tsianakas, Christoph M. Schempp, Kim Petersen, Mia M. Noergaard, Lluis Puig

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial

    Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H tri... by Kristian Reich, Lars Erik Kristensen, Saxon D. Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2

    Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2 by Byung Soo Kim, Seong Jin Jo, SangWoong Youn, Kristian Reich, Carine Saadoun, Chia-Ling Chang, Ya-Wen Yang, Yu-Huei Huang, Tsen-Fang Tsai

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)

    Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL) by Jean-Philippe Lacour, Anthony Bewley, Edward Hammond, Jes B. Hansen, Laura Horne, Carle Paul, Kristian Reich, Julien Seneschal, Clara De Simone, Anne Sohrt, Matthias Augustin, Giovanni Pellacani

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional Study

    Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional Study by Florian Anzengruber, Matthias Augustin, Marc A. Radtke, Diamant Thaci, Nikhil Yawalkar, Markus Streit, Kristian Reich, Mathias Drach, Christina Sorbe, Lars E. French, Ulrich Mrowietz, Julia-Tatjana Maul, Peter H. Itin, Alexander A. Navarini

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

    Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure by April Armstrong, Carle Paul, Luis Puig, Wolf Henning Boehncke, Michael Freeman, Hideshi Torii, Kim Papp, Christopher E. M. Griffiths, Andrew Blauvelt, Kristian Reich, Melinda Gooderham, Tadashi Terui, Lisa Renda, Noah Agada, Wen Xu, Gaia Gallo, Mark G. Lebwohl

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

    Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials by Craig Leonardi, Kristian Reich, Peter Foley, Hideshi Torii, Sascha Gerdes, Lyn Guenther, Melinda Gooderham, Laura K. Ferris, Christopher E. M. Griffiths, Hany ElMaraghy, Heidi Crane, Himanshu Patel, Russel Burge, Gaia Gallo, David Shrom, Ann Leung, Chen-Yen Lin, Kim Papp

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  13. 13
    Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

    Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Cl... by Alice B. Gottlieb, Atul Deodhar, Iain B. Mcinnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Kwaku Marfo, Hanno B. Richards, Luminita Pricop, Abhijit Shete, Vivek Trivedi, Deborah Keefe, Charis C. Papavassilis, Piotr Jagiello, Philemon Papanastasiou, Philip J. Mease, Mark Lebwohl

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: